Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: Rationale and protocol

Trials

Volumn 12, Issue , 2011, Pages

  Chang, Anne B ^a,b,c   Grimwood, Keith ^b,c   White, Andrew V ^d   Maclennan, Carolyn ^e   Sloots, Theo P ^b,c   Sive, Alan ^d   McCallum, Gabrielle B ^a   Mackay, Ian M ^b,c   Morris, Peter S ^a,e  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d JAMES COOK UNIVERSITY   (Australia)

^e ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; PLACEBO; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; AUSTRALIA; BACTERIOLOGY; BRONCHIOLITIS; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPOTHESIS; INFANT; LONG TERM CARE; MEDICAL RECORD; MORBIDITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PUBLISHING; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; TREATMENT DURATION; VIROLOGY; ABORIGINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ETHNOLOGY; LENGTH OF STAY; METHODOLOGY; MICROBIOLOGY; NEWBORN; PLACEBO EFFECT; PRESCHOOL CHILD; RECURRENT DISEASE; TIME; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BRONCHIOLITIS; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; OXYGEN INHALATION THERAPY; PATIENT READMISSION; PLACEBO EFFECT; QUEENSLAND; RECURRENCE; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953885202     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-94     Document Type: Article

References (44)

1. Subcommittee on Diagnosis and Management of Bronchiolitis Diagnosis and Management of Bronchiolitis. Pediatrics 2006, 118:1774-1793. 10.1542/peds.2006-2223, 17015575, Subcommittee on Diagnosis and Management of Bronchiolitis.
2. Reeve CA, Whitehall JS, Buettner PG, Norton R, Reeve DM, Francis F. Predicting respiratory syncytial virus hospitalisation in Australian children. J Paediatr Child Health 2006, 42:248-252. 10.1111/j.1440-1754.2006.00849.x, 16712553.
3. Fitzgerald DA, Kilham HA. Bronchiolitis: assessment and evidence-based management. Med J Aust 2004, 180:399-404.
4. Li SQ, Guthridge SL, d'Espaignet ET, Paterson BA. From infancy to young adulthood: health status in the Northern Territory 2006. Department of Health andCommunity Services, Darwin 2007,
5. O'Grady KA, Torzillo PJ, Chang AB. Hospitalisation of Indigenous children in the Northern Territory for lower respiratory illness in the first year of life. Med J Aust 2010, 192:586-590.
6. Bailey EJ, Maclennan C, Morris PS, Kruske SG, Brown N, Chang AB. Risks of severity and readmission of Indigenous and non-Indigenous children hospitalised for bronchiolitis. J Paediatr Child Health 2009, 45:593-597. 10.1111/j.1440-1754.2009.01571.x, 19751375.
7. Valery PC, Torzillo PJ, Mulholland EK, Boyce NC, Purdie DM, Chang AB. A hospital-based case-control study of bronchiectasis in Indigenous children in Central Australia. Pediatr Infect Dis J 2004, 23:902-908. 10.1097/01.inf.0000142508.33623.2f, 15602188.
8. Tennant PWG, Gibson JG, Pearce MS. Lifecourse predictors of adult respiratory function: results from the Newcastle Thousand Families Study. Thorax 2008, 63:823-830. 10.1136/thx.2008.096388, 18408051.
9. Maritz G, Probyn M, De MR, Snibson K, Harding R. Lung parenchyma at maturity is influenced by postnatal growth but not by moderate preterm birth in sheep. Neonatology 2008, 93:28-35. 10.1159/000105522, 17630495.
10. Snibson K, Harding R. Postnatal growth rate, but not mild preterm birth, influences airway structure in adult sheep challenged with house dust mite. Exp Lung Res 2008, 34:69-84. 10.1080/01902140701807720, 18266130.
11. Pinkerton KE, Joad JP. The mammalian respiratory system and critical windows of exposure for children's health. Environ Health Perspect 2000, 108(Suppl 3):457-462. 10.2307/3454537, 1637815, 10852845.
12. Australian Health Ministers' Advisory Council 2 Aboriginal and Torres Strait Islander Health Performance Framework Report. 2008, AHMAC, Canberra, 2008, Australian Health Ministers' Advisory Council 2.
13. Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ. Non-CF bronchiectasis-clinical and HRCT evaluation. Pediatr Pulmonol 2003, 35:477-483. 10.1002/ppul.10289, 12746947.
14. Chang AB. Editorial. Bronchiectasis: so much yet to learn and to do. Paediatr Respir Rev 2011,
15. Arden KE, McErlean P, Nissen MD, Sloots TP, Mackay IM. Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J Med Virol 2006, 78:1232-1240. 10.1002/jmv.20689, 16847968.
16. Kramer BW, Kallapur S, Newnham J, Jobe AH. Prenatal inflammation and lung development. Semin Fetal Neonatal Med 2009, 14:2-7. 10.1016/j.siny.2008.08.011, 2652840, 18845493.
17. Kallapur SG, Jobe AH. Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed 2006, 91:F132-F135. 10.1136/adc.2004.068544, 2672671, 16492951.
18. Branden E, Koyi H, Gnarpe J, Gnarpe H, Tornling G. Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection. Scand J Infect Dis 2004, 36:811-816. 10.1080/00365540512331336622, 15764166.
19. Webley WC, Tilahun Y, Lay K, Patel K, Stuart ES, Andrzejewski C, Salva PS. Rate of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections. Eur Respir J 2009, 33:360-367. 10.1183/09031936.00019508, 19010996.
20. Greenberg D, Banerji A, Friedman MG, Chiu CH, Kahane S. High rate of Simkania negevensis among Canadian inuit infants hospitalized with lower respiratory tract infections. Scand J Infect Dis 2003, 35:506-508. 10.1080/00365540310014648, 14514154.
21. Bloomfield P, Dalton D, Karleka A, Kesson A, Duncan G, Isaacs D. Bacteraemia and antibiotic use in respiratory syncytial virus infections. Arch Dis Child 2004, 89:363-367. 10.1136/adc.2003.035105, 1719865, 15033849.
22. Spurling GK, Fonseka K, Doust J, Del MC. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev 2007, CD005189.
23. Bogaert D, de GR, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154. 10.1016/S1473-3099(04)00938-7, 14998500.
24. Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J 1994, 13:983-989. 10.1097/00006454-199411000-00009, 7845752.
25. Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010, 23:590-615. 10.1128/CMR.00078-09, 20610825.
26. Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J 2007, 29:91-97. 10.1183/09031936.00029206, 17050564.
27. Kneyber MC, van Woensel JB, Uijtendaal E, Uiterwaal CS, Kimpen JL. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: A randomized equivalence trial. Pediatr Pulmonol 2008, 43:142-149. 10.1002/ppul.20748, 18085694.
28. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration 2005, 72:233-238. 10.1159/000085362, 15942290.
29. Bordley WC, Viswanathan M, King VJ, Sutton SF, Jackman AM, Sterling L, Lohr KN. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med 2004, 158:119-126. 10.1001/archpedi.158.2.119, 14757603.
30. Calogero C, Sly PD. Acute viral bronchiolitis: to treat or not to treat-that is the question. J Pediatr 2007, 151:235-237. 10.1016/j.jpeds.2007.05.041, 17719928.
31. Dawson K, Kennedy D, Asher I, Cooper D, Cooper P, Francis P, Henry R, Le SP, Martin J, Masters B, et al. The management of acute bronchiolitis. Thoracic Society of Australia and New Zealand. J Paediatr Child Health 1993, 29:335-337. 10.1111/j.1440-1754.1993.tb00529.x, 8018135.
32. Bolisetty S, Wheaton G, Chang AB. Respiratory syncytial virus infection and immunoprophylaxis for selected high-risk children in Central Australia. Aust J Rural Health 2005, 13:265-270. 10.1111/j.1440-1584.2005.00715.x, 16171499.
33. Chang AB, Torzillo PJ, Boyce NC, White AV, Stewart PA, Wheaton GR, Purdie DM, Wakerman J, Valery PC. Zinc and Vitamin-A supplementation in Indigenous children hospitalised with episodes of lower respiratory tract infection: a randomised controlled trial. Med J Aust 2006, 184:107-112.
34. Korppi M. How should we study responses to treatment in children with bronchiolitis?. Pediatr Pulmonol 2007, 42:984-985. 10.1002/ppul.20627, 17588244.
35. Hare KM, Grimwood K, Leach AJ, Smith-Vaughan HC, Torzillo PJ, Morris P, Chang AB. Respiratory bacterial pathogens in the nasopharynx and lower airways of Australian Indigenous children with bronchiectasis. J Pediatr 2010, 157:1001-1005. 10.1016/j.jpeds.2010.06.002, 20656297.
36. Stubbs E, Hare K, Wilson C, Morris P, Leach AJ. Streptococcus pneumoniae and noncapsular Haemophilus influenzae nasal carriage and hand contamination in children: a comparison of two populations at risk of otitis media. Pediatr Infect Dis J 2005, 24:423-428. 10.1097/01.inf.0000160945.87356.ca, 15876941.
37. Hare KM, Morris P, Smith-Vaughan H, Leach AJ. Random colony selection versus colony morphology for detection of multiple pneumococcal serotypes in nasopharyngeal swabs. Pediatr Infect Dis J 2008, 27:178-180.
38. Chang AB, Clark R, Acworth JP, Petsky HL, Sloots TP. The impact of viral respiratory infection on the severity and recovery from an asthma exacerbation. Pediatr Infect Dis J 2009, 28:290-294. 10.1097/INF.0b013e31819067b1, 19258918.
39. Arden KE, Chang AB, Lambert SB, Nissen M, Sloots TP, Mackay IM. Newly identified respiratory viruses in children with asthma exacerbation not requiring admission into hospital. J Med Virology 2010, 82:1458-1461.
40. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials 2010, 11:32. 10.1186/1745-6215-11-32, 2857832, 20334632.
41. Chang AB, Masel JP, Boyce NC, Torzillo PJ. Respiratory morbidity in central Australian Aboriginal children with alveolar lobar abnormalities. Med J Aust 2003, 178:490-494.
42. Steinkamp G, Schmitt-Grohe S, Doring G, Staab D, Pfrunder D, Beck G, Schubert R, Zielen S. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection. Respir Med 2008, 102:1643-1653. 10.1016/j.rmed.2008.03.009, 18701270.
43. Gielen V, Johnston SL, Edwards MR. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur Respir J 2010, 36:646-654. 10.1183/09031936.00095809, 20150207.
44. Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol 2006, 35:99-102. 10.1016/j.jcv.2005.09.008, 16257260.